Xie Yili Kevin 4
4 · HUMANIGEN, INC · Filed Jul 29, 2022
Insider Transaction Report
Form 4
HUMANIGEN, INCHGEN
Xie Yili Kevin
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-27+83,418→ 83,418 totalExercise: $0.38From: 2023-07-27Exp: 2032-07-26→ Common Stock (83,418 underlying)
Footnotes (1)
- [F1]The stock option vests in two equal installments on the first and second anniversaries of the grant date.